| Lactose (India) Ltd | 123 Cr. | 97.7 | 137/84.3 | 25.5 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.02/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,513 Cr. | 319 | 479/192 | 73.5 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 28.2 Cr. | 38.0 | 79.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 87.8 Cr. | 59.9 | 59.9/17.0 | 351 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 64.3 Cr. | 85.4 | 115/69.7 | 18.4 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 57,268 Cr. | 2,030 | 2,286/1,275 | 21.2 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 290 Cr. | 11.9 | 17.2/10.8 | 16.6 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 933 Cr. | 1,739 | 1,999/635 | 27.4 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 103 Cr. | 20.6 | 29.8/17.0 | 29.8 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 963 Cr. | 327 | 399/219 | 10.9 | 133 | 0.76 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.75 Cr. | 13.1 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.79 Cr. | 3.13 | 8.28/2.11 | 4.43 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 369 Cr. | 380 | 536/211 | 63.2 | 0.00 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,768 Cr. | 1,107 | 1,511/944 | 41.0 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 45.0 Cr. | 0.22 | 1.12/0.20 | 2.96 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 28.2 Cr. | 10.7 | 26.3/9.96 | 13.8 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 8.23 Cr. | 8.15 | 13.0/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 153 Cr. | 430 | 805/415 | 10.7 | 596 | 0.35 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 83.8 Cr. | 83.8 | 92.5/26.1 | 158 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 11,997 Cr. | 1,149 | 2,150/1,100 | 37.8 | 174 | 0.93 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 6.62 Cr. | 52.6 | 88.7/36.1 | 13.5 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 15.5 Cr. | 104 | 153/74.3 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 51.5 Cr. | 94.2 | 144/12.2 | 25.0 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.3 Cr. | 40.1 | 69.0/33.0 | 48.8 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.36 Cr. | 17.8 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 6,231 Cr. | 359 | 1,028/353 | 21.2 | 72.4 | 0.33 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 80.8 Cr. | 18.7 | 28.8/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.0 Cr. | 21.6 | 30.0/17.4 | 1,096 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 85,735 Cr. | 2,076 | 2,727/2,029 | 48.5 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 251 Cr. | 435 | 524/241 | 24.0 | 123 | 1.03 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 63.9 Cr. | 44.5 | 47.9/26.7 | 86.4 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 67,333 Cr. | 1,160 | 1,279/994 | 19.1 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 188 Cr. | 302 | 317/159 | 63.8 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 776 Cr. | 77.4 | 115/68.0 | 18.6 | 32.6 | 1.94 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 31.7 Cr. | 24.3 | 39.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 17,576 Cr. | 2,143 | 2,170/930 | 61.2 | 173 | 0.07 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.82 Cr. | 0.73 | 1.06/0.51 | 68.8 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 211 Cr. | 27.5 | 45.6/23.1 | 11.9 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.63 Cr. | 14.8 | 19.1/7.60 | 288 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 136 Cr. | 5.79 | 6.57/2.82 | 317 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 56,157 Cr. | 26,460 | 37,000/26,006 | 36.8 | 1,888 | 1.80 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,534 Cr. | 722 | 972/557 | 30.3 | 226 | 0.69 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 202 Cr. | 71.3 | 100/31.3 | 58.8 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,617 Cr. | 1,367 | 1,740/752 | | 93.5 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,298 Cr. | 1,433 | 1,870/1,110 | 214 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 929 Cr. | 265 | 330/154 | 21.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 60.6 Cr. | 7.35 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,051 Cr. | 787 | 873/278 | 13.8 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,628 Cr. | 373 | 728/361 | 25.0 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,318 Cr. | 934 | 1,402/925 | 18.9 | 768 | 1.07 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,42,548 Cr. | 4,211 | 4,325/2,886 | 61.8 | 250 | 0.76 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 844 Cr. | 91.6 | 195/75.2 | | 41.3 | 0.55 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,266 Cr. | 13.6 | 23.5/11.5 | 18.4 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 12,484 Cr. | 326 | 1,328/303 | 41.5 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,546 Cr. | 153 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,13,924 Cr. | 1,724 | 1,851/1,547 | 34.1 | 324 | 0.93 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,127 Cr. | 478 | 734/440 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,457 Cr. | 370 | 375/175 | 39.6 | 81.2 | 0.11 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,440 Cr. | 329 | 502/260 | 36.4 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,242 Cr. | 4,010 | 6,718/3,966 | 25.0 | 340 | 2.92 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,219 Cr. | 1,946 | 2,725/1,772 | 30.6 | 335 | 1.03 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,316 Cr. | 5,018 | 6,739/4,904 | 28.3 | 373 | 2.49 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 122 Cr. | 34.7 | 76.0/34.5 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,593 Cr. | 5,150 | 5,993/3,701 | 31.0 | 841 | 0.68 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 126 Cr. | 102 | 135/81.0 | 9.03 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,165 Cr. | 353 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,363 Cr. | 664 | 1,065/604 | 129 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 17,480 Cr. | 13,620 | 19,748/10,060 | 97.6 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 254 Cr. | 13.1 | 31.0/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,930 Cr. | 890 | 1,060/660 | 10.2 | 483 | 0.67 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,124 Cr. | 38.7 | 70.5/33.5 | 27.8 | 21.8 | 0.52 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,213 Cr. | 181 | 271/156 | 22.8 | 59.3 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 50.9 Cr. | 32.1 | 108/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 240 Cr. | 67.2 | 129/65.3 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,01,816 Cr. | 2,227 | 2,263/1,774 | 20.5 | 430 | 0.54 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,275 Cr. | 635 | 679/440 | 14.5 | 357 | 0.28 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 56,099 Cr. | 1,040 | 1,141/512 | 70.1 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,494 Cr. | 1,440 | 1,599/596 | 26.1 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 126 Cr. | 59.5 | 114/51.0 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 643 Cr. | 133 | 215/120 | 38.8 | 104 | 2.25 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 572 Cr. | 329 | 500/265 | 22.0 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 14,140 Cr. | 890 | 1,250/802 | 30.6 | 414 | 0.56 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 31,864 Cr. | 1,984 | 2,008/1,303 | 42.3 | 243 | 0.78 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,168 Cr. | 175 | 302/155 | 27.4 | 37.9 | 1.43 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,694 Cr. | 1,491 | 1,595/1,168 | 35.7 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,174 Cr. | 74.1 | 127/57.5 | 17.5 | 59.7 | 1.35 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,157 Cr. | 142 | 150/67.2 | 24.4 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,891 Cr. | 203 | 350/190 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,538 Cr. | 206 | 457/177 | 102 | 96.9 | 0.68 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,353 Cr. | 1,582 | 2,350/1,243 | 33.0 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,960 Cr. | 294 | 410/284 | 58.6 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,108 Cr. | 581 | 627/412 | 26.0 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 57,122 Cr. | 2,025 | 2,286/1,275 | 21.1 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,863 Cr. | 2,590 | 3,516/2,220 | 43.6 | 101 | 1.63 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,475 Cr. | 1,851 | 2,131/1,200 | 25.7 | 610 | 0.97 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,193 Cr. | 381 | 528/357 | 26.7 | 149 | 1.31 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 18,684 Cr. | 1,346 | 1,910/1,097 | 42.1 | 227 | 0.55 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,092 Cr. | 1,283 | 1,380/1,020 | 19.2 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,098 Cr. | 198 | 322/178 | 23.5 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,08,937 Cr. | 1,348 | 1,673/1,282 | 22.9 | 408 | 0.96 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,003 Cr. | 1,712 | 2,397/1,551 | 21.2 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 224 Cr. | 76.4 | 166/58.4 | 10.4 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,433 Cr. | 230 | 244/105 | 22.0 | 107 | 0.22 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 56.1 Cr. | 34.4 | 57.2/28.5 | 20.3 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 61,416 Cr. | 379 | 425/291 | 74.8 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,146 Cr. | 1,135 | 2,000/1,099 | 26.6 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 125 Cr. | 79.0 | 129/64.0 | 15.3 | 49.2 | 1.52 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 272 Cr. | 116 | 205/69.0 | 23.8 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,179 Cr. | 8,891 | 10,691/6,502 | 107 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,809 Cr. | 625 | 791/544 | 31.3 | 118 | 0.74 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 144 Cr. | 70.5 | 125/61.0 | 12.2 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 65,328 Cr. | 5,464 | 5,934/4,492 | 27.2 | 1,116 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,187 Cr. | 774 | 1,108/725 | 22.9 | 271 | 1.42 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 431 Cr. | 754 | 959/663 | 44.9 | 690 | 0.66 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 36,943 Cr. | 2,959 | 3,021/2,022 | 36.4 | 345 | 0.95 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,386 Cr. | 302 | 367/258 | 23.5 | 133 | 1.72 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,415 Cr. | 374 | 575/312 | 18.4 | 147 | 0.53 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,018.50 Cr | 1,105.68 | | 57.41 | 201.33 | 0.37% | 16.29% | 15.20% | 6.10 |